Ankasa Regenerative Therapeutics Garners $8,500,000 Series A Funding

  • Feed Type
  • Date
    6/23/2015
  • Company Name
    Ankasa Regenerative Therapeutics
  • Mailing Address
    Undisclosed La Jolla, CA 92037 USA
  • Company Description
    Pharmaceutical preparations including reactivated stem cells for organ and tissue re-growth, tissue repair, and healing.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Ankasa intends to initially develop a proprietary localized therapy involving WNT3A for spinal fusion surgery patients.
  • M&A Terms
  • Venture Investor
  • Venture Investor